Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study

Renaud Tamisier (Grenoble, France), Renaud Tamisier, Thibaud Damy, Jean-Marc Davy, Patrick Levy, Laurent Morin, Jean-Louis Pepin, Marie-Pia D’Ortho

Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Renaud Tamisier (Grenoble, France), Renaud Tamisier, Thibaud Damy, Jean-Marc Davy, Patrick Levy, Laurent Morin, Jean-Louis Pepin, Marie-Pia D’Ortho. Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study. Eur Respir J 2015; 46: Suppl. 59, 4761

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
FACE: A prospective multicentre observational cohort study in patients with chronic heart failure (CHF) and central sleep apnoea (CSA) treated with adaptive servoventilation (ASV)
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013


LATE-BREAKING ABSTRACT: Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Late Breaking Abstract - FACE: Prospective multicenter cohort adressing chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV): patient baseline characteristics
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019

LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


Late Breaking Abstract - FACE: Cluster phenotyping predicting outcomes in a prospective multicenter cohort study of chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV).
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019



Late Breaking Abstract - Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study_Update
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017



Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Timely association between obstructive sleep apnea (OSA) and cardiovascular outcome after first acute myocardial infarction (AMI): A national wide population-based study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Prevalence of metabolic syndrome (MS) in a population of apneic patients:A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


LATE-BREAKING ABSTRACT: ORCADES: a prospective cohort study of severe obstructive sleep apnoea (OSA) patients receiving second line-treatment with a mandibular repositioning device (MRD)
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013


A randomized controlled trial of auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ)
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016

Severe obstructive sleep apnea syndrome in elderly population: A prospective study of 80 patients
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015

Elevated risk of motor vehicle accidents in patients with obstructive sleep apnea syndrome: A case-control study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


LATE-BREAKING ABSTRACT: Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results
Source: International Congress 2015 – Latest developments in clinical studies in acute and chronic lung diseases
Year: 2015


Gender variations regarding long term effect of CPAP on blood pressure in hypertensive patients with obstructive sleep apnea. A prospective study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Efficacy of auto servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-Stokes respiration (CSR). A randomized CPAP-controlled trial
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010


Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


LATE-BREAKING ABSTRACT: Heart rate variability (HRV) in patients with severe obstructive sleep apnea syndrome (OSA) and its response to a 3-month continuous positive airway pressure (CPAP) therapy
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015